Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb 21;14(1):16-22.
doi: 10.1007/BF01989220.

Detection of contamination with antineoplastic agents in a hospital pharmacy department

Affiliations

Detection of contamination with antineoplastic agents in a hospital pharmacy department

P J Sessink et al. Pharm Weekbl Sci. .

Abstract

The contamination with fluorouracil, cyclophosphamide and methotrexate was studied in a hospital pharmacy department where these drugs were prepared. In the preparation room, air samples were taken before and during preparation of the drugs. Methotrexate was detected in one sample which was collected during preparation (0.3 micrograms/m3). Spot samples were taken in the vertical laminar airflow safety hood before and after preparation of the drugs and after cleaning of the hood. Contamination of the laminar airflow hood was: cyclophosphamide: 1-160 ng/cm2; fluorouracil: 10-62 ng/cm2 and methotrexate: 2-633 ng/cm2. Spot samples from the floor in front of and beneath the laminar airflow hood showed contamination with especially fluorouracil (48-236 micrograms/m2). The gloves used during preparation of the drugs were contaminated mainly with fluorouracil (5-980 ng/cm2). Urine samples from two workers involved in the preparation of the drugs were analysed for unmetabolized cyclophosphamide; it was not detected. Although no uptake of cyclophosphamide was established, it is shown that the methods for measurement of cyclophosphamide, fluorouracil and methotrexate in the preparation room are applicable for the control of occupational exposure to these drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):607-10 - PubMed
    1. Am J Hosp Pharm. 1982 Nov;39(11):1881-7 - PubMed
    1. Scand J Work Environ Health. 1980 Dec;6(4):299-301 - PubMed
    1. Environ Mol Mutagen. 1990;15(2):83-92 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1974 Aug;35(2):98-106 - PubMed

Publication types